The Philips Azurion interventional imaging system was recently updated with new ultralow dose technology that is said to reduce X-ray exposure by up to 50% during coronary procedures.
There are numerous radiotracers specifically designed to identify prostate cancer, but experts say one may be superior to the others at both the patient and lesion level.
These findings present additional evidence that invasive imaging tests are not necessarily more effective when it comes to evaluating patients for chest pain.